Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics

    Preclinical toxicology studies are performed prior to phase I trials with novel cancer therapeutics to identify a safe clinical starting dose and potential human toxicities. The primary aim of this study was t...

    D R Newell, S S Burtles, B W Fox, D I Jodrell, T A Connors in British Journal of Cancer (1999)

  2. No Access

    Article

    Suitability of cisplatin solutions for 14-day continuous infusion by ambulatory pump

    The stability of cisplatin (DDP) solutions (1 and 1.6 mg/ml in saline-mannitol) in plastic infusion bags was studied for up to 14 days at 25° C, 37° C and 60° C. Small changes in the solution were observed, bu...

    M. Hrubiško, A. T. Mc Gown, J. A. Prendiville in Cancer Chemotherapy and Pharmacology (1992)

  3. No Access

    Article

    Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy

    Verapamil was shown to be capable of increasing intracellular daunorubicin levels in normal lymphocytes isolated from patients undergoing chemotherapy for epithelial ovarian cancer. The extent of the increase ...

    A. T. McGown, D. Murphy, D. Crowther, B. W. Fox in Cancer Chemotherapy and Pharmacology (1991)

  4. No Access

    Article

    An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin

    The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplat...

    C. Ewen, A. Perera, J. H. Hendry, C. A. McAuliffe in Cancer Chemotherapy and Pharmacology (1988)

  5. No Access

    Chapter and Conference Paper

    Mechanisms of Drug Resistance in Screening

    Resistance is a term which should only properly be applied to a single cell. It is the description of the sensitivity which a single cell exhibits towards a drug, applying particularly to the case where the se...

    B. W. Fox in Human Tumour Xenografts in Anticancer Drug Development (1988)

  6. No Access

    Article

    Comparative studies of DNA cross-linking reactions following methylene dimethanesulphonate and its hydrolytic product, formaldehyde

    The technique of alkaline elution was employed to study the interactions of methylene dimethane sulphonate (MDMS) and formaldehyde (HCHO) with DNA from Yoshida lymphosarcoma cells treated with these agents. MD...

    P. M. O'Connor, B. W. Fox in Cancer Chemotherapy and Pharmacology (1987)

  7. No Access

    Article

    Cross-linking between histones and DNA following treatment with a series of dimethane sulphonate esters

    The cross-linking on the nucleohistone to the associated DNA by a series of methaneusulphonates of the busulphan series (CH3SO2O(CH2) n OSO2CH3) from n=4–9 has been studied by ge...

    J. A. Hartley, B. W. Fox in Cancer Chemotherapy and Pharmacology (1986)

  8. No Access

    Article

    In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera

    The in vivo distribution in man of the four platinum derivatives cis-dichlorodiammine platinum(II) (DDP), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV) (CHIP), cis-dichloro-bis-cyclopropylamin...

    S. E. Owens, N. Thatcher, H. Sharma, N. Adam in Cancer Chemotherapy and Pharmacology (1985)

  9. No Access

    Article

    Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24

    B.W Fox in British Journal of Cancer (1985)

  10. No Access

    Article

    Anticancer and Interferon Agents: Synthesis and Properties - Drugs and Parmacutical Sciences - Vol. 24

    B.W Fox in British Journal of Cancer (1985)

  11. No Access

    Chapter

    Principles of Chemotherapy

    The principles underlying the administration of cytotoxic drugs for the treatment of malignant disease differ fundamentally from those of bacterial, fungal, or antiviral infections in that it is not possible t...

    P. M. Wilkinson, B. W. Fox in The Radiotherapy of Malignant Disease (1985)

  12. No Access

    Article

    Molecular aspects of anti-cancer drug action Topics in molecular and structural biology

    B.W Fox in British Journal of Cancer (1984)

  13. No Access

    Chapter

    Dialkanesulphonates and Chromatin

    It was recognised by Finley and co-workers in 1964 (1) that the dialkanesulphonates were a potent group of antitumour agents which, in some but not all cases, also produced a bone marrow depressant action. The...

    B. W. Fox, P. Bedford, J. Hartley in Cancer Chemotherapy and Selective Drug Development (1984)

  14. No Access

    Chapter

    Mechanisms of Resistance to Anticancer Agents

    Resistance to antitumor agents has been known to occur within tumour tissue since its discovery by Burchenal and his colleagues in 1950. Its meaning in the experimental laboratory may differ from that in the c...

    B. W. Fox in Cancer Chemotherapy and Selective Drug Development (1984)

  15. No Access

    Article

    Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients

    The blood and urinary clearances of cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA, JM8) were determined in four patients with malignancy. A 40 μCi iv injection of 191Pt/193Pt (3:1)-labelled CBDCA...

    H. Sharma, N. Thatcher, J. Baer, A. Zaki, A. Smith in Cancer Chemotherapy and Pharmacology (1983)

  16. No Access

    Article

    A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II)

    Three platinum derivatives, cis-dichlorodiammine platinum (II), (DDP), cis-trans-dichlorodihydroxy-bis-(isopropylamine)platinum (IV) (CHIP) and cis-dichloro-bis-cyclopropylamine platinum (II) (CP), have been p...

    R. Harrison, C. A. McAuliffe, A. Zaki, J. Baer in Cancer Chemotherapy and Pharmacology (1983)

  17. No Access

    Article

    Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease

    The blood clearances of three platinum compounds, cis-dichlorodiammine platinum II (DDP), cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV (CHIP), and cis-dichloro-bis-cyclopropylamine platinum II...

    N. Thatcher, H. Sharma, R. Harrison, A. Smith in Cancer Chemotherapy and Pharmacology (1982)

  18. No Access

    Article

    Effects of Drugs on the Cell Nucleus

    B W Fox in British Journal of Cancer (1980)

  19. No Access

    Article

    Mitomycin C. Current Status and Developments

    B W Fox in British Journal of Cancer (1980)

  20. No Access

    Article

    Moulds, Toxins and Food

    B W Fox in British Journal of Cancer (1980)

previous disabled Page of 3